Australian Immunotherapy Selected for Revolutionary US Clinical Trial Platform Debut

An Australian immunotherapy drug will receive a huge boost when it is tested with four other new concepts across 54 clinical sites across the USA in a search for an effective treatment for ALS (a motor neuron disease). This bold initiative will see Implicit Bioscience’s IC14 entering an elite pivotal clinical study in the first […]